Yu EY, Piulats JM, Gravis G, Fong PCC, et al. Corrigendum to "Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study" [Eur Urol 83 (2023) 15-26]. Eur Urol 2022 Dec 15:S0302-2838(22)02844-5. doi: 10.1016/j.eururo.2022.
PMID: 36528479